Viewing Study NCT01872416

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:46 AM
Ignite Modification Date: 2026-01-04 @ 8:50 AM
Study NCT ID: NCT01872416
Status: UNKNOWN
Last Update Posted: 2013-06-18
First Post: 2013-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Refractory and relapsed small cell lung cancer View
None Liposomal Doxorubicin View
None ifosfamide View